Gene · 5873
Papers3,592
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,592
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibitory effects of gallic acid on the activity of exosomal secretory pathway in breast cancer cell lines: A possible anticancer impact. | Bioimpacts | 2022 | 36644548 | PubTator, text mining | PubMed |
| Circ_0000799 promotes proliferation and invasion in colorectal cancer and epithelial-mesenchymal transition. | J Gastrointest Oncol | 2022 | 36636042 | PubTator, text mining | PubMed |
| Neutrophil dynamics and inflammaging in acute ischemic stroke: A transcriptomic review. | Front Aging Neurosci | 2022 | 36620775 | PubTator, text mining | PubMed |
| Role of tumor-derived exosomes in metastasis, drug resistance and diagnosis of clear cell renal cell carcinoma. | Front Oncol | 2022 | 36620603 | PubTator, text mining | PubMed |
| Hemophagocytic Lymphohistiocytosis Associated with Synergistic Defects of AP3B1 and ATM Genes: A Case Report and Literature Review. | J Clin Med | 2022 | 36614895 | PubTator, text mining | PubMed |
| The Role of Long Noncoding RNA (lncRNAs) Biomarkers in Renal Cell Carcinoma. | Int J Mol Sci | 2022 | 36614082 | PubTator, text mining | PubMed |
| Role of miRNA in Melanoma Development and Progression. | Int J Mol Sci | 2022 | 36613640 | PubTator, text mining | PubMed |
| Current Status of Research on Small Extracellular Vesicles for the Diagnosis and Treatment of Urological Tumors. | Cancers (Basel) | 2022 | 36612097 | PubTator, text mining | PubMed |
| Tumor-Derived Extracellular Vesicles in Cancer Immunoediting and Their Potential as Oncoimmunotherapeutics. | Cancers (Basel) | 2022 | 36612080 | PubTator, text mining | PubMed |
| Anti-CD73 antibody activates human B cells, enhances humoral responses and induces redistribution of B cells in patients with cancer. | J Immunother Cancer | 2022 | 36600561 | PubTator, text mining | PubMed |
| Precision medicine: The use of tailored therapy in primary immunodeficiencies. | Front Immunol | 2022 | 36569887 | PubTator, text mining | PubMed |
| End-stage Renal Disease in Griscelli Syndrome. | Indian J Nephrol | 2022 | 36568594 | PubTator, text mining | PubMed |
| Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer. | J Transl Med | 2022 | 36564797 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Drug Targets and Delivery Vehicles for Cancer Therapy. | Pharmaceutics | 2022 | 36559315 | PubTator, text mining | PubMed |
| Diverse Neutrophil Functions in Cancer and Promising Neutrophil-Based Cancer Therapies. | Int J Mol Sci | 2022 | 36555469 | PubTator, text mining | PubMed |
| Exosomes in Cerebral Ischemia-Reperfusion Injury: Current Perspectives and Future Challenges. | Brain Sci | 2022 | 36552117 | PubTator, text mining | PubMed |
| Current Understanding of the Role of Senescent Melanocytes in Skin Ageing. | Biomedicines | 2022 | 36551868 | PubTator, text mining | PubMed |
| Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer. | Cancers (Basel) | 2022 | 36551580 | PubTator, text mining | PubMed |
| Melanogenesis and the Targeted Therapy of Melanoma. | Biomolecules | 2022 | 36551302 | PubTator, text mining | PubMed |
| Engineering Human Mesenchymal Bodies in a Novel 3D-Printed Microchannel Bioreactor for Extracellular Vesicle Biogenesis. | Bioengineering (Basel) | 2022 | 36551001 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5873/papers?page=32